脊柱病理风险的新型遗传标记鉴定:两项生物样本库的全基因组关联研究
基于英国生物样本库389413名参与者,对腰椎滑脱、椎管狭窄、退变性椎间盘疾病及脊柱融合术后假关节形成进行全基因组回归分析,并在FinnGen中外部验证。研究在多个染色体位点发现与上述4种脊柱病理相关的核苷酸变异,部分变异在FinnGen中重复验证,为病理机制提供潜在线索。证据等级为预后III级。
要点
- 英国生物样本库纳入389413名参与者,对4种脊柱病理进行全基因组关联分析。
- 腰椎滑脱、椎管狭窄、退变性椎间盘疾病和假关节形成分别涉及不同染色体位点的基因变异。
- 椎管狭窄和退变性椎间盘疾病的部分变异在FinnGen中重复验证。
核心结论
- 本研究揭示了与4种不同脊柱病理潜在相关的特定基因位点核苷酸变异,为病理机制提供潜在见解。
研究设计与样本
- 从英国生物样本库识别腰椎滑脱、椎管狭窄、退变性椎间盘疾病及脊柱融合术后假关节形成的病例,对照为无相应诊断的患者,采用全基因组回归检验与各表型发生潜在相关的遗传变异,并在FinnGen中进行外部验证。
- 英国生物样本库共识别389413名参与者。
主要发现
- 染色体2上跨越GFPT1、NFU1、AAK1和LOC124906020的位点与腰椎滑脱相关。
- 染色体2和12上跨越GFPT1、NFU1和PDE3A的两个位点与椎管狭窄相关。
- 染色体6、10和15上跨越CHST3、LOC102723493和SMAD3的三个位点与退变性椎间盘疾病相关。
- 染色体5和9上的两个新位点与假关节形成相关,其中染色体9位点对应LOC105376270基因。
- 椎管狭窄和退变性椎间盘疾病的部分变异在FinnGen中也得到重复验证。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Identifying genetic risk factors for spinal disorders may lead to knowledge regarding underlying molecular mechanisms and the development of new treatments. METHODS: Cases of lumbar spondylolisthesis, spinal stenosis, degenerative disc disease, and pseudarthrosis after spinal fusion were identified from the UK Biobank. Controls were patients without the diagnosis. Whole-genome regressions were used to test for genetic variants potentially implicated in the occurrence of each phenotype. External validation was performed in FinnGen. RESULTS: A total of 389,413 participants were identified from the UK Biobank. A locus on chromosome 2 spanning GFPT1, NFU1, AAK1, and LOC124906020 was implicated in lumbar spondylolisthesis. Two loci on chromosomes 2 and 12 spanning genes GFPT1, NFU1, and PDE3A were implicated in spinal stenosis. Three loci on chromosomes 6, 10, and 15 spanning genes CHST3, LOC102723493, and SMAD3 were implicated in degenerative disc disease. Finally, 2 novel loci on chromosomes 5 and 9, with the latter corresponding to the LOC105376270 gene, were implicated in pseudarthrosis. Some of these variants associated with spinal stenosis and degenerative disc disease were also replicated in FinnGen. CONCLUSIONS: This study revealed nucleotide variations in select genetic loci that were potentially implicated in 4 different spinal pathologies, providing potential insights into the pathological mechanisms. LEVEL OF EVIDENCE: Prognostic Level III . See Instructions for Authors for a complete description of levels of evidence.
引用
- Bovonratwet P, Kulm S, Kolin DA, et al. Identification of Novel Genetic Markers for the Risk of Spinal Pathologies: A Genome-Wide Association Study of 2 Biobanks. J Bone Joint Surg Am. 2023. PMID: 36927824. doi:10.2106/JBJS.22.00872
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。